Ontrak (OTRK) 10-K 28 Feb 17 2016 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2016	Feb. 24, 2017	Jun. 30, 2015
Document Information [Line Items]
Entity Registrant Name	CATASYS, INC.
Entity Central Index Key	1,136,174
Trading Symbol	cats
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		55,288,458
Entity Public Float			$ 3,986,460
Document Type	10-K
Document Period End Date	Dec. 31, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY
Amendment Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Current assets
Cash and cash equivalents	$ 851,000	$ 916,000
Receivables, net of allowance for doubtful accounts of $0 and $0, respectively	1,052,000	590,000
Prepaids and other current assets	420,000	575,000
Total current assets	2,323,000	2,081,000
Long-term assets
Property and equipment, net of accumulated depreciation of $1,620 and $1,491, respectively	410,000	412,000
Deposits and other assets	371,000	387,000
Total Assets	3,104,000	2,880,000
Current liabilities
Accounts payable	870,000	753,000
Accrued compensation and benefits	2,089,000	1,703,000
Deferred revenue	1,525,000	1,683,000
Other accrued liabilities	575,000	682,000
Short term debt, related party, net of discount of $216 and $0, respectively	9,796,000
Short term derivative liability	8,122,000
Total current liabilities	22,977,000	4,821,000
Long-term liabilities
Deferred rent and other long-term liabilities	117,000	198,000
Capital leases	31,000	66,000
Long term derivative liability		2,348,000
Warrant liabilities	5,307,000	509,000
Total Liabilities	28,432,000	11,604,000
Commitments and contingencies (note 8)
Stockholders' deficit
Preferred stock, $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $0.0001 par value; 500,000,000 shares authorized; 55,288,458 and 55,007,761 shares issued and outstanding at December 31, 2016 and December 31, 2015, respectively	6,000	6,000
Additional paid-in-capital	254,385,000	253,053,000
Accumulated deficit	(279,719,000)	(261,783,000)
Total Stockholders' deficit	(25,328,000)	(8,724,000)
Total Liabilities and Stockholders' Deficit	3,104,000	2,880,000
Affiliated Entity [Member]
Long-term liabilities
Long term convertible debt, related party, net of discount $0 and $0, respectively		$ 3,662,000

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Receivables, allowance for doubtful accounts	$ 0	$ 0
Property and equipment, accumulated dereciation	1,620	1,491
Short term debt, net of discount	$ 216	$ 0
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	55,288,458	55,007,761
Common stock, shares outstanding (in shares)	55,288,458	55,007,761
Affiliated Entity [Member]
Long term convertible debt discount	$ 0	$ 0

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Revenues:
Healthcare services revenues	$ 7,075,000	$ 2,705,000
Operating expenses
Cost of healthcare services	4,670,000	2,433,000
General and administrative	8,838,000	9,049,000
Depreciation and amortization	141,000	122,000
Total operating expenses	13,649,000	11,604,000
Loss from operations	(6,574,000)	(8,899,000)
Interest and other income	106,000	64,000
Interest expense	(5,354,000)	(2,590,000)
Loss on impairment of intangible assets		(88,000)
Loss on exchange of warrants	0	(4,410,000)
Loss on debt extinguishment	(2,424,000)	(195,000)
Change in fair value of warrant liability	2,093,000	11,665,000
Change in fair value of derivative liability	(5,774,000)	(2,761,000)
Loss from operations before provision for income taxes	(17,927,000)	(7,214,000)
Provision for income taxes	9,000	9,000
Net loss	$ (17,936,000)	$ (7,223,000)
Basic and diluted net loss per share: (in dollars per share)	$ (0.33)	$ (0.18)
Basic weighted number of shares outstanding (in shares)	55,074	40,372

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2014	25,244,485
Balance at Dec. 31, 2014	$ 3,000	$ 213,333,000		$ (254,560,000)	$ (41,224,000)
Warrant Exchange (in shares)	21,277,220
Warrant Exchange	$ 2,000	35,531,000			35,533,000
Common stock issued for outside services (in shares)	76,055
Common stock issued for outside services	$ 172,000	172,000			172,000
Common stock issued in private placement, net of expenses (in shares)	8,410,001
Common stock issued in private placement, net of expenses	$ 1,000	2,620,000			2,621,000
Share-based Compensation Expense		1,397,000			1,397,000
Net loss				(7,223,000)	(7,223,000)
Balance (in shares) at Dec. 31, 2015	55,007,761
Balance at Dec. 31, 2015	$ 6,000	253,053,000		(261,783,000)	(8,724,000)
Common stock issued for outside services (in shares)	235,000
Common stock issued for outside services	$ 235,000	235,000			235,000
Share-based Compensation Expense		697,000			697,000
Net loss				(17,936,000)	(17,936,000)
Balance (in shares) at Dec. 31, 2016	55,288,458
Balance at Dec. 31, 2016	$ 6,000	254,385,000		(279,719,000)	(25,328,000)
Warrants Exercised (in shares)	45,697
Warrants Exercised		46,000			46,000
Extinguishment of Debt		$ 354,000			$ 354,000

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Operating activities:
Net loss	$ (17,936,000)	$ (7,223,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	141,000	122,000
Loss on disposal of intangible assets		88,000
Amortization of debt discount and issuance costs included in interest expense	4,651,000	2,324,000
Loss on debt extinguishment	2,424,000	195,000
Provision for doubtful accounts	47,000	10,000
Deferred rent	(70,000)	(44,000)
Share-based compensation expense	697,000	1,397,000
Fair value adjustment on warrant liability	(2,093,000)	(11,665,000)
Loss on exchange of warrants	0	4,410,000
Fair value adjustment on derivative liability	5,774,000	2,761,000
Changes in current assets and liabilities:
Receivables	(509,000)	(111,000)
Prepaids and other current assets	155,000	17,000
Deferred revenue	(158,000)	1,329,000
Accounts payable and other accrued liabilities	916,000	882,000
Net Cash Provided by (Used in) Operating Activities, Continuing Operations	(5,726,000)	(5,168,000)
Investing activities:
Purchases of property and equipment	(106,000)	(107,000)
Deposits and other assets	16,000
Net cash used in investing activities	(90,000)	(107,000)
Financing activities:
Proceeds from the issuance of common stock and warrants		2,463,000
Proceeds from the issuance of convertible debt, related party	300,000	5,910,000
Payments on convertible debenture		(2,681,000)
Proceeds from the issuance of senior promissory note, related party	5,505,000
Transactions costs		(185,000)
Capital lease obligations	(54,000)	(24,000)
Net cash provided by financing activities	5,751,000	5,483,000
Net increase (decrease) in cash and cash equivalents	(65,000)	208,000
Cash and cash equivalents at beginning of period	916,000	708,000
Cash and cash equivalents at end of period	851,000	916,000
Supplemental disclosure of cash paid
Interest	149,000	271,000
Income taxes	48,000	41,000
Supplemental disclosure of non-cash activity
Common stock issued for exercise of warrants	46,000
Property and equipment acquired through capital leases and other financing	34,000	54,000
Warrants Issued for Services [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Issuance of stock and warrants		168,000
Common Stock Issued for Consulting Services [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Issuance of stock and warrants	$ 235,000	$ 172,000

Note 1 - Summary of Significant

Note 1 - Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Significant Accounting Policies [Text Block]	Note 1. Description of Business We provide data analytics based specialized behavioral health management and integrated treatment services to health plans through our On Trak Trak 52 Trak Basis of Consolidation and Presentation and Going Concern Our financial statements have been prepared on the basis that we will continue as a going concern. At December 31, 2016, $851,000 $20.7 twelve December 31, 2016, $5.7 twelve December 31, 2016, We expect our current cash resources to cover expenses through March 31, 2017; may Our ability to fund our ongoing operations and continue as a going concern is dependent on increasing the number of members that are eligible for our programs by signing new contracts and generating fees from existing and new contracts and the success of management’s plan to increase revenue and continue to control expenses. We currently operate our On Trak 2017. All inter-company transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts in the financial statements and disclosed in the accompanying notes. Significant areas requiring the use of management estimates include expense accruals, accounts receivable allowances, accrued claims payable, the useful life of depreciable and amortizable assets, the evaluation of asset impairment, the valuation of warrant liabilities, the valuation of derivative liabilites, and shared-based compensation. Actual results could differ from those estimates. Revenue Recognition Our Catasys contracts are generally designed to provide cash fees to us on a monthly basis based on enrolled members. To the extent our contracts may may twelve Cost of Services Cost of healthcare services consists primarily of salaries related to our care coaches, healthcare provider claims payments, and fees charged by our third third Trak TM Share-Based Compensation Our 2010 1,825,000 422A ten three five December 31, 2016, 1,464,089 303,674 Total share-based compensation expense attributable to operations were $697,000 $1.4 December 31, 2016 2015, Stock Options – Employees and Directors We measure and recognize compensation expense for all share-based payment awards made to employees and directors based on estimated fair values on the date of grant. We estimate the fair value of share-based payment awards using the Black-Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the consolidated statements of operations. There were no December 31, 2016 1.3 December 31, 2015. Stock Options and Warrants – Non-employees We account for the issuance of stock options and warrants for services from non-employees by estimating the fair value of stock options and warrants issued using the Black-Scholes pricing model. This model’s calculations incorporate the exercise price, the market price of shares on grant date, the weighted average risk-free interest rate, expected life of the option or warrant, expected volatility of our stock and expected dividends. For options and warrants issued as compensation to non-employees for services that are fully vested and non-forfeitable at the time of issuance, the estimated value is recorded in equity and expensed when the services are performed and benefit is received. For unvested shares, the change in fair value during the period is recognized in expense using the graded vesting method. From time to time, we have retained terminated employees as part-time consultants upon their departure from the company. Because the employees continue to provide services to us, their options continue to vest in accordance with the original terms. Due to the change in classification of the option awards, the options are considered modified at the date of termination. The modifications are treated as exchanges of the original awards in return for the issuance of new awards. At the date of termination, the unvested options are no longer accounted for as employee awards under FASB’s accounting rules for share-based expense but are instead accounted for as new non-employee awards. The accounting for the portion of the total grants that have already vested and have been previously expensed as equity awards is not changed. There were no employees moved to consulting status for the twelve December 31, 2016. one twelve December 31, 2015. 100% December 31, 2016. Income Taxes We account for income taxes using the liability method in accordance with Accounting Standards Committee (“ASC”) 740 Basic and Diluted Income ( Loss ) per Share Basic income (loss) per share is computed by dividing the net income (loss) to common stockholders for the period by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of shares of common stock and dilutive common equivalent shares outstanding during the period. Common equivalent shares, consisting of approximately 9,344,214 3,277,744 December 31, 2016 2015, Cash and Cash Equivalents We consider all highly liquid investments with an original maturity of three may December 31, 2016, $676,000. Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between (1) (2) three three Level Input: Input Definition: Level I Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date. Level II Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date. Level III Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The following tables summarize fair value measurements by level at December 31, 2016 2015, Balance at December 31, 2015 (Amounts in thousands) Level I Level II Level III Total Certificates of deposit 122 - - 122 Total assets 122 - - 122 Warrant liabilities - - 509 509 Derivative Liability - - 2,348 2,348 Total liabilities - - 2,857 2,857 Balance at December 31, 2016 (Amounts in thousands) Level I Level II Level III Total Certificates of deposit 106 - - 106 Total assets 106 - - 106 Warrant liabilities - - 5,307 5,307 Derivative Liability 8,122 8,122 Total liabilities - - 13,429 13,429 Financial instruments classified as Level III in the fair value hierarchy as of December 31, 2016, Warrant Liabilities The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the years ended December 31, 2016 2015: Level III Level III Warrant Derivative (Dollars in thousands) Liabilities (Dollars in thousands) Liabilities Balance as of December 31, 2014 $ 40,585 Balance as of December 31, 2014 $ - Issuance (exercise) of warrants, net 2,712 Issuance (exercise) of derivatives, net 1,019 Change in fair value (11,665 ) Change in fair value 2,761 Exchange of warrants (31,123 ) Debt Modification (1,432 ) Balance as of December 31, 2015 $ 509 Balance as of December 31, 2015 $ 2,348 Issuance (exercise) of warrants, net 4,821 Issuance (exercise) of derivatives, net - Change in fair value (2,093 ) Change in fair value 5,774 Warrant Exchanged 2,070 Debt Modification - Balance as of December 31, 2016 $ 5,307 Balance as of December 31, 2016 $ 8,122 Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from two seven five seven Capital Leases Assets held under capital leases include computer equipment, and are recorded at the lower of the net present value of the minimum lease payments or the fair value of the leased asset at the inception of the lease. Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets. All lease agreements meet at least one four 840 Warrant Liabilities In conjunction with the Securities Purchase Agreements entered into in April 2015 “April five 530,303 $2.00 may “April 2015 April 2015 $0.30 September July 2016, 66,288 April 2015 464,015 April 2015 December 31, 2016. In May 2015, 21,277,220 $0.58 December 2011 May 2014, 21,277,220 $0 $4.4 December 31, 2016 2015, In July 2015, $3.55 12% January 18, 2016 “July 2015 100% five 935,008 $1.90 may “July 2015 The conversion price of the July 2015 $1.90 may July 2015 12% In September 2015, July 2015 July 2015 $0.30 1.5 $463,000 “September In March 2016, $900,000 $900,000 “March 2016 March 2016 30 8% 12% five 450,000 $0.47 “March 2016 640,909 March 2016 $0.33 May 2016 In April 2016, March 2016 $400,000, $1.3 “April five 200,000 $0.47 “April 2016 284,848 April 2016 $0.33 May 2016 In May 2016, April 2016 $405,000, $1.7 “May five 306,818 $0.33 “May 2016 In June 2016, May 2016 $480,000, $2.2 “June 2016 five 363,636 $0.33 “June 2016 In July 2016, June 2016 $570,000, $2.8 “July 2016 five 431,818 $0.33 “July 2016 In August 2016, three $2.8 “August 2016 five 875,000 $1.10 “August 2016 The August 2016 August 2016 August 2016 August 2016 In addition, in August 2016, July 2016 $2.8 August 2016 2,028,029 $0.33 2,993,561 $1.10 August 2016 In December 2016, August 2016 $5.6 8% March 15, 2017 five forty (40%) 2,022,835 $1.10 “December 2016 The December 2016 December 2016 December 2016 December 2016 December 2016 In December 2016, $300,000 8% March 31, 2017 “December 2016 five seventy five (75%) 264,706 December 2016 $0.85 The Shamus Warrants include price protection provisions pursuant to which, subject to certain exempt issuances, the then exercise price of the Shamus Warrants will be adjusted if the Company issues shares of common stock at a price that is less than the then exercise price of the Shamus Warrants. Such mechanism will remain in effect until the earliest of (i) the termination date of the Shamus Warrants, (ii) such time as the Shamus Warrants are exercised or (iii) contemporaneously with the listing of our shares of common stock on a registered national securities exchange. The warrant liabilities were calculated using the Black-Scholes model based on upon the following assumptions: December 31, 2016 December 31, 2015 Expected volatility 104.31% 133.19% Risk-free interest rate 1.20% - 1.93% 0.65 - 1.76% Weighted average expected lives in years 2.25 - 4.99 0.99 - 4.29 Expected dividend 0% 0% For the years ended December 31, 2016 2015, $2.1 $11.7 Concentration of Credit Risk Financial instruments, which potentially subject us to a concentration of risk, include cash and accounts receivable. All of our customers are based in the United States at this time and we are not subject to exchange risk for accounts receivable. The Company maintains its cash in domestic financial institutions subject to insurance coverage issued by the Federal Deposit Insurance Corporation (FDIC). Under FDIC rules, the company is entitled to aggregate coverage as defined by the Federal regulation per account type per separate legal entity per financial institution. The Company has incurred no losses as a result of any credit risk exposures. For the year ended December 31, 2016, two 78% two 81% For the year ended December 31, 2015, three 82% three 90% Derivative Liability In July 2015, $3.55 12% January 18, 2016 “July 2015 July 2015 $1.90 may October 2015, July 2015 July 2015 January 18, 2016 January 18, 2017. July 2015 $0.30 July 2015 12% July 2015 December 31, 2016 December 31, 2015 Expected volatility 104.31 % 133.19 % Risk-free interest rate 0.44 % 0.23 % Weighted average expected lives in years 0.05 1.05 Expected dividend 0 % 0 % The expected volatility assumption for the twelve December 31, 2016 2016 107 110), For the twelve December 31, 2016 2015, $5.8 $2.8 Recently Issued or Newly Adopted Accounting Pronouncements In April 2016, 2016 10, Revenue from Contracts with Customers (Topic 606) 2014 09, 2014 09, December 15, 2017. In March 2016, 2016 09, Compensation — Stock Compensation (Topic 718): 2016 09”), December 15, 2016, 2016 09 In February 2015, Consolidation (Topic 810): 2015 02”). 2015 02 2015 02 December 15, 2015, 2015 02 In August 2014, 2014 15, Presentation of Financial Statements—Going Concern (Subtopic 205 40): 2014 15”) . 2014 15 may one one 2014 15 December 15, 2016. 2014 15

Note 2 - Accounts Receivable

Note 2 - Accounts Receivable	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	Note 2 . Accounts Receivable Accounts receivables consisted of the following as of December 31, 2016 2015: December 31, (in thousands) 2016 2015 Healthcare fees $ 1,050 $ 587 Other 2 3 Total receivables $ 1,052 $ 590 Less allowance for doubtful accounts - - Total receivables, net $ 1,052 $ 590 We use the specific identification method for recording the provision for doubtful accounts, which was $0 December 31, 2016 2015.

Note 3 - Property and Equipment

Note 3 - Property and Equipment	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	Note 3 . Property and Equipment Property and equipment consisted of the following as of December 31, 2016 2015: (in thousands) 2016 2015 Furniture and equipment $ 1,712 $ 1,585 Leasehold improvements 318 318 Total property and equipment 2,030 1,903 Less accumulated depreciation and amortization (1,620 ) (1,491 ) Total property and equipment, net $ 410 $ 412 Depreciation expense was $141,000 $110,000 December 31, 2016 2015,

Note 4 - Capital Lease Obligati

Note 4 - Capital Lease Obligations	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Capital Leases in Financial Statements of Lessee Disclosure [Text Block]	Note 4. We lease certain computer equipment under agreements entered into during 2016 $103,000 $110,000 December 31, 2016 2015, December 31, 2016 2015 $47,000 $43,000, The future minimum lease payments required under the capital leases and the present values of the net minimum lease payments as of December 31, 2016, (in thousands) Amount Year ending December 31, 2017 $ 46 2018 34 2019 2 Total minimum lease payments 82 Less amounts representing interest (11 ) Capital lease obligations, net of interest 71 Less current maturities of capital lease obligations (40 ) Long-term capital lease obligations $ 31

Note 5 - Income Taxes

Note 5 - Income Taxes	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Income Tax Disclosure [Text Block]	Note 5. As of December 31, 2016, $222 $170 2024, 2016. seven The primary components of temporary differences which give rise to our net deferred tax assets are as follows: 2016 2015 (in thousands) Federal, state and foreign net operating losses $ 78,466 $ 78,474 Stock based compensation 7,429 7,879 Accrued liabilities 664 585 Other temporary differences 4,894 3,045 Valuation allowance (91,453 ) (89,983 ) $ - $ - The Company has provided a valuation allowance in full on its net deferred tax assets in accordance with ASC 740 740. A reconciliation between the statutory federal income tax rate and the effective income tax rate for the years ended December 31, 2016 2015 Federal statutory rate -34.0 % -34.0 % State taxes, net of federal benefit 26.2 % 16.8 % Non-deductible goodwill 0.0 % 0.0 % ISO / ESPP 0.2 % 2.1 % Other -0.5 % -27.0 % Change in valuation allowance 8.0 % 42.1 % Tax provision -0.1 % 0.0 % Current accounting rules require that companies recognize in the consolidated financial statements the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position. We file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. Tax years that remain subject to examinations by tax authorities are 2011 2015. 2011. December 31, 2016, The Company has adopted guidance issued by the FASB that clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold of more likely than not and a measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. In making this assessment, a company must determine whether it is more likely than not that a tax position will be sustained upon examination, based solely on the technical merits of the position and must assume that the tax position will be examined by taxing authorities. Our policy is to include interest and penalties related to unrecognized tax benefits in income tax expense. There were no December 31, 2016 2015, 2010, 2011.

Note 6 - Equity Financings

Note 6 - Equity Financings	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Equity Financing [Text Block]	Note 6 . Equity Financings In October 2015, $2.0 6.7 $0.30 In September 2015, 1.5 $463,000 “September May 2015, 21,277,220 $0.58 December 2011 May 2014, 21,277,220

Note 7 - Share-based Compensati

Note 7 - Share-based Compensation	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	Note 7 . Share-based Compensation The Plan provides for the issuance of up to 1,825,000 422A stock appreciation rights, limited stock appreciation rights and restricted stock grants are authorized under the Plan. We grant all such share-based compensation awards at no less than the fair market value of our stock on the date of grant, and have granted stock and stock options to executive officers, employees, members of our Board of Directors and certain outside consultants. The terms and conditions upon which options become exercisable vary among grants; however, option rights expire no later than ten three five December 31, 2016, 1,464,089 303,674 $697,000 $1.4 December 31, 2016 2015, Stock Options – Employees and Directors There were no 2016. There were 250,000 2015. For the twelve December 31, 2015, 1,050,000 Stock option activity for employee and director grants is summarized as follows: Weighted Avg. Shares Exercise Price Balance, December 31, 2014 378,000 $ 19.59 2015 Granted 1,300,000 2.20 Cancelled/Expired (207,000 ) 3.29 Balance, December 31, 2015 1,471,000 $ 6.51 2016 Granted - - Cancelled/Expired (7,000 ) 11.31 Balance, December 31, 2016 1,464,000 $ 6.49 The weighted average remaining contractual life and weighted average exercise price of options outstanding as of December 31, 2016 Options Outstanding Options Exercisable Range of Exercise Prices Shares Weighted Average Remaining Life (yrs) Weighted Average Price Shares Weighted Average Price $0.00 to $20.00 1,455,000 7.07 $ 5.48 1,293,000 $ 5.89 $20.01 to $1,000.00 9,000 2.03 158.98 9,000 158.98 1,464,000 7.04 $ 6.46 1,302,000 $ 6.99 Share-based compensation expense relating to stock options granted to employees and directors was $697,000 $1.4 December 31, 2016 2015, As of December 31, 2016, $318,000 1.3 Stock Options and Warrants – Non-employees In addition to stock options granted under the Plan, we have also granted options and warrants to purchase our common stock to certain non-employees that have been approved by our Board of Directors. There were no 2016 2015, Warrants granted to non-employees outstanding as of December 31, 2016 2015, December 31, 2016 Description Shares Weighted Average Exercise Price Warrants issued in connection with equity offering - $ - Warrants issued in connection with debt agreement 6,156,102 0.85 Warrants issued for services - - 6,156,102 $ 0.85 December 31, 2015 Description Shares Weighted Average Exercise Price Warrants issued in connection with equity offering - $ - Warrants issued in connection with debt agreement 1,465,311 0.30 Warrants issued for services 341,251 2.16 1,806,562 $ 0.65 There were no twelve December 31, 2016. 300,000 twelve December 31, 2015. Share-based compensation expense relating to stock options and warrants granted to non-employees amounted to $0 $3,000 December 31, 2016 2015, Common Stock In October 2015, 200,000 April In May 2015, 21,277,220 $0.58 December 2011 May 2014, 21,277,220 During 2016 2015, 235,000 76,000 $235,000 $172,000, Employee Stock Purchase Plan Our qualified employee stock purchase plan (ESPP), approved by our Board of Directors and shareholders and adopted in June 2006, 90 85% first 10% December 31, 2016, December 31, 2016 2015,

Note 8 - Commitments and Contin

Note 8 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 8 . Commitments and Contingencies Operating Lease Commitments We incurred rent expense of approximately $296,000 $294,000 December 31, 2016 2015, Our principal executive and administrative offices are located in Los Angeles, California and consist of leased office space totaling approximately 9,120 April 2019. $31,000 Rent expense is calculated using the straight-line method based on the total minimum lease payments over the initial term of the lease. Landlord tenant Future minimum payments, by year and in the aggregate, under non-cancelable operating leases with initial or remaining terms of one December 31, 2016: (In thousands) Year Amount 2017 $ 376 2018 $ 387 2019 $ 99 Clinical Research Commitments None. Legal Proceedings From time to time, we may December 31, 2016.

Note 9 - Related Party Disclosu

Note 9 - Related Party Disclosure	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	Note 9 . Related Party Disclosure Mr. Gorlin, an affiliate of the company, entered into securities purchase agreements during the fiscal year ended December 31, 2015, 300,000 $90,000. Terren Peizer, Chairman and Chief Executive Officer, transferred his securities ownership in Catasys to Acuitas from Crede Capital Group, LLC during 2015. 100% In August 2016, $225,000. $225,000 August 2016 In August 2016, $2.8 August 2016 2,028,029 $0.33 2,993,561 $1.10 August 2016 In December 2016, August 2016 $2.8 8% March 15, 2017 five forty (40%) $1.10 “December 2016 Acuitas entered into securities purchase agreements as of December 31, 2015 6,953,334 $2.1 935,008 $0.30 December 31, 2015. In addition, we have a $3.7 $577,000 December 31, 2016. $194,000 $130,000 December 31, 2016 2015, In August 2016, $ 1.0 five 318,182 $1.10 3 In December 2016, $1.0 8% March 15, 2017 five forty (40%) 363,636 $1.10 In addition, in December 2016, $300,000 8% March 31, 2017 “December 2016 five seventy five (75%) 264,706 December 2016 $0.85 Shamus entered into securities purchase agreements during the fiscal years ended December 31, 2015 956,667 $287,000.

Note 10 - Short-term Debt

Note 10 - Short-term Debt	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 10 . Short -term Debt In April 2015, $2.0 $2.12 12% January 18, 2016 “April 2015 April 2015 April 2015 April 17, 2015. $1,815,000. $560,000 first second 2015. The conversion price of the April 2015 April 2015 $2.00 may April 2015 12% April 2015 $0.30 September In July 2015, $3.35 $3.35 August 21, 2015, 8% 12% $2.2 April 2015 April 2015 In July 2015, July 2015 July 2015 The conversion price of the July 2015 $1.90 may July 2015 12% The conversion price of the July 2015 July 2015 $0.30 September In October 2015, July 2015 July 2015 January 18, 2016 January 18, 2017 December 31, 2015 June 30, 2016. 470 50, $195,000 In March 2016, $900,000 $900,000 “March 2016 March 2016 30 8% 12% five 450,000 $0.47 “March 2016 640,909 March 2016 $0.33 May 2016 In April 2016, March 2016 $400,000, $1.3 “April five 200,000 $0.47 “April 2016 284,848 April 2016 $0.33 May 2016 In May 2016, April 2016 $405,000, $1.7 “May five 306,818 $0.33 “May 2016 In June 2016, May 2016 $480,000, $2.2 “June 2016 five 363,636 $0.33 “June 2016 In July 2016, June 2016 $570,000, $2.8 “July 2016 five 431,818 $0.33 “July 2016 In August 2016, $225,000. $225,000 August 2016 In August 2016, three $2.8 “August 2016 five 875,000 $1.10 “August 2016 The August 2016 August 2016 August 2016 August 2016 In addition, in August 2016, July 2016 $2.8 August 2016 2,028,029 $0.33 2,993,561 $1.10 In December 2016, August 2016 $5.6 8% March 15, 2017 five forty (40%) 2,022,835 $1.10 “December 2016 The December 2016 December 2016 December 2016 December 2016 December 2016 In December 2016, $300,000 8% March 31, 2017 “December 2016 five seventy five (75%) 264,706 December 2016 $0.85 The Shamus Warrants include price protection provisions pursuant to which, subject to certain exempt issuances, the then exercise price of the Shamus Warrants will be adjusted if the Company issues shares of common stock at a price that is less than the then exercise price of the Shamus Warrants. Such mechanism will remain in effect until the earliest of (i) the termination date of the Shamus Warrants, (ii) such time as the Shamus Warrants are exercised or (iii) contemporaneously with the listing of our shares of common stock on a registered national securities exchange.

Note 11 - Subsequent Events

Note 11 - Subsequent Events	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Subsequent Events [Text Block]	Note 11. Financing Activities In January 2017, $1,300,000 8% March 31, 2017 “January 2017 five one (100%) January 2017 $0.85 “January 2017 March 2017. December 2016 25% 827,293 The January 2017 January 2017 January 2017 January 2017 January 2017 In connection with the Subscription Agreement described above, the number of Shamus Warrants were increased from 75% 100% 352,941 2017 On February 27, 2017, 2017 “2017 2017 2017 14,000,000 2017 1,500,000 2010 This description is qualified in its entirety by reference to the actual terms of the 2017 14C, February 28, 2017.

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Basis of Consolidation and Presentation and Going Concern Our financial statements have been prepared on the basis that we will continue as a going concern. At December 31, 2016, $851,000 $20.7 twelve December 31, 2016, $5.7 twelve December 31, 2016, We expect our current cash resources to cover expenses through March 31, 2017; may Our ability to fund our ongoing operations and continue as a going concern is dependent on increasing the number of members that are eligible for our programs by signing new contracts and generating fees from existing and new contracts and the success of management’s plan to increase revenue and continue to control expenses. We currently operate our On Trak 2017. All inter-company transactions have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts in the financial statements and disclosed in the accompanying notes. Significant areas requiring the use of management estimates include expense accruals, accounts receivable allowances, accrued claims payable, the useful life of depreciable and amortizable assets, the evaluation of asset impairment, the valuation of warrant liabilities, the valuation of derivative liabilites, and shared-based compensation. Actual results could differ from those estimates.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition Our Catasys contracts are generally designed to provide cash fees to us on a monthly basis based on enrolled members. To the extent our contracts may may twelve
Cost of Sales, Policy [Policy Text Block]	Cost of Services Cost of healthcare services consists primarily of salaries related to our care coaches, healthcare provider claims payments, and fees charged by our third third Trak TM
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Share-Based Compensation Our 2010 1,825,000 422A ten three five December 31, 2016, 1,464,089 303,674 Total share-based compensation expense attributable to operations were $697,000 $1.4 December 31, 2016 2015, Stock Options – Employees and Directors We measure and recognize compensation expense for all share-based payment awards made to employees and directors based on estimated fair values on the date of grant. We estimate the fair value of share-based payment awards using the Black-Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the consolidated statements of operations. There were no December 31, 2016 1.3 December 31, 2015. Stock Options and Warrants – Non-employees We account for the issuance of stock options and warrants for services from non-employees by estimating the fair value of stock options and warrants issued using the Black-Scholes pricing model. This model’s calculations incorporate the exercise price, the market price of shares on grant date, the weighted average risk-free interest rate, expected life of the option or warrant, expected volatility of our stock and expected dividends. For options and warrants issued as compensation to non-employees for services that are fully vested and non-forfeitable at the time of issuance, the estimated value is recorded in equity and expensed when the services are performed and benefit is received. For unvested shares, the change in fair value during the period is recognized in expense using the graded vesting method. From time to time, we have retained terminated employees as part-time consultants upon their departure from the company. Because the employees continue to provide services to us, their options continue to vest in accordance with the original terms. Due to the change in classification of the option awards, the options are considered modified at the date of termination. The modifications are treated as exchanges of the original awards in return for the issuance of new awards. At the date of termination, the unvested options are no longer accounted for as employee awards under FASB’s accounting rules for share-based expense but are instead accounted for as new non-employee awards. The accounting for the portion of the total grants that have already vested and have been previously expensed as equity awards is not changed. There were no employees moved to consulting status for the twelve December 31, 2016 2015,
Income Tax, Policy [Policy Text Block]	Income Taxes We account for income taxes using the liability method in accordance with Accounting Standards Committee (“ASC”) 740
Earnings Per Share, Policy [Policy Text Block]	Basic and Diluted Income ( Loss ) per Share Basic income (loss) per share is computed by dividing the net income (loss) to common stockholders for the period by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of shares of common stock and dilutive common equivalent shares outstanding during the period. Common equivalent shares, consisting of approximately 9,344,214 3,277,744 December 31, 2016 2015,
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents We consider all highly liquid investments with an original maturity of three may December 31, 2016, $676,000.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between (1) (2) three three Level Input: Input Definition: Level I Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date. Level II Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date. Level III Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The following tables summarize fair value measurements by level at December 31, 2016 2015, Balance at December 31, 2015 (Amounts in thousands) Level I Level II Level III Total Certificates of deposit 122 - - 122 Total assets 122 - - 122 Warrant liabilities - - 509 509 Derivative Liability - - 2,348 2,348 Total liabilities - - 2,857 2,857 Balance at December 31, 2016 (Amounts in thousands) Level I Level II Level III Total Certificates of deposit 106 - - 106 Total assets 106 - - 106 Warrant liabilities - - 5,307 5,307 Derivative Liability 8,122 8,122 Total liabilities - - 13,429 13,429 Financial instruments classified as Level III in the fair value hierarchy as of December 31, 2016, Warrant Liabilities The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the years ended December 31, 2016 2015: Level III Level III Warrant Derivative (Dollars in thousands) Liabilities (Dollars in thousands) Liabilities Balance as of December 31, 2014 $ 40,585 Balance as of December 31, 2014 $ - Issuance (exercise) of warrants, net 2,712 Issuance (exercise) of derivatives, net 1,019 Change in fair value (11,665 ) Change in fair value 2,761 Exchange of warrants (31,123 ) Debt Modification (1,432 ) Balance as of December 31, 2015 $ 509 Balance as of December 31, 2015 $ 2,348 Issuance (exercise) of warrants, net 4,821 Issuance (exercise) of derivatives, net - Change in fair value (2,093 ) Change in fair value 5,774 Warrant Exchanged 2,070 Debt Modification - Balance as of December 31, 2016 $ 5,307 Balance as of December 31, 2016 $ 8,122
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from two seven five seven
Lease, Policy [Policy Text Block]	Capital Leases Assets held under capital leases include computer equipment, and are recorded at the lower of the net present value of the minimum lease payments or the fair value of the leased asset at the inception of the lease. Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets. All lease agreements meet at least one four 840
Warrant Liabilities, Policy [Policy Text Block]	Warrant Liabilities In conjunction with the Securities Purchase Agreements entered into in April 2015 “April five 530,303 $2.00 may “April 2015 April 2015 $0.30 September July 2016, 66,288 April 2015 464,015 April 2015 December 31, 2016. In May 2015, 21,277,220 $0.58 December 2011 May 2014, 21,277,220 $0 $4.4 December 31, 2016 2015, In July 2015, $3.55 12% January 18, 2016 “July 2015 100% five 935,008 $1.90 may “July 2015 The conversion price of the July 2015 $1.90 may July 2015 12% In September 2015, July 2015 July 2015 $0.30 1.5 $463,000 “September In March 2016, $900,000 $900,000 “March 2016 March 2016 30 8% 12% five 450,000 $0.47 “March 2016 640,909 March 2016 $0.33 May 2016 In April 2016, March 2016 $400,000, $1.3 “April five 200,000 $0.47 “April 2016 284,848 April 2016 $0.33 May 2016 In May 2016, April 2016 $405,000, $1.7 “May five 306,818 $0.33 “May 2016 In June 2016, May 2016 $480,000, $2.2 “June 2016 five 363,636 $0.33 “June 2016 In July 2016, June 2016 $570,000, $2.8 “July 2016 five 431,818 $0.33 “July 2016 In August 2016, three $2.8 “August 2016 five 875,000 $1.10 “August 2016 The August 2016 August 2016 August 2016 August 2016 In addition, in August 2016, July 2016 $2.8 August 2016 2,028,029 $0.33 2,993,561 $1.10 August 2016 In December 2016, August 2016 $5.6 8% March 15, 2017 five forty (40%) 2,022,835 $1.10 “December 2016 The December 2016 December 2016 December 2016 December 2016 December 2016 In December 2016, $300,000 8% March 31, 2017 “December 2016 five seventy five (75%) 264,706 December 2016 $0.85 The Shamus Warrants include price protection provisions pursuant to which, subject to certain exempt issuances, the then exercise price of the Shamus Warrants will be adjusted if the Company issues shares of common stock at a price that is less than the then exercise price of the Shamus Warrants. Such mechanism will remain in effect until the earliest of (i) the termination date of the Shamus Warrants, (ii) such time as the Shamus Warrants are exercised or (iii) contemporaneously with the listing of our shares of common stock on a registered national securities exchange. The warrant liabilities were calculated using the Black-Scholes model based on upon the following assumptions: December 31, 2016 December 31, 2015 Expected volatility 104.31% 133.19% Risk-free interest rate 1.20% - 1.93% 0.65 - 1.76% Weighted average expected lives in years 2.25 - 4.99 0.99 - 4.29 Expected dividend 0% 0% For the years ended December 31, 2016 2015, $2.1 $11.7
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentration of Credit Risk Financial instruments, which potentially subject us to a concentration of risk, include cash and accounts receivable. All of our customers are based in the United States at this time and we are not subject to exchange risk for accounts receivable. The Company maintains its cash in domestic financial institutions subject to insurance coverage issued by the Federal Deposit Insurance Corporation (FDIC). Under FDIC rules, the company is entitled to aggregate coverage as defined by the Federal regulation per account type per separate legal entity per financial institution. The Company has incurred no losses as a result of any credit risk exposures. For the year ended December 31, 2016, two 78% two 81% For the year ended December 31, 2015, three 82% three 90%
Derivatives, Policy [Policy Text Block]	Derivative Liability In July 2015, $3.55 12% January 18, 2016 “July 2015 July 2015 $1.90 may October 2015, July 2015 July 2015 January 18, 2016 January 18, 2017. July 2015 $0.30 July 2015 12% July 2015 December 31, 2016 Expected volatility 104.31 % Risk-free interest rate 0.44 % Weighted average expected lives in years 0.05 Expected dividend 0 % The expected volatility assumption for the twelve December 31, 2016 2015 107 110), For the twelve December 31, 2016 2015, $5.8 $2.8
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued or Newly Adopted Accounting Pronouncements In April 2016, 2016 10, Revenue from Contracts with Customers (Topic 606) 2016 10”), 2014 09, 2014 09 December 15, 2017. In March 2016, 2016 09, Compensation — Stock Compensation (Topic 718): 2016 09”), December 15, 2016, 2016 09 In February 2015, Consolidation (Topic 810): 2015 02”). 2015 02 2015 02 December 15, 2015, 2015 02 In August 2014, 2014 15, Presentation of Financial Statements—Going Concern (Subtopic 205 40): 2014 15”) . 2014 15 may one one 2014 15 December 15, 2016. 2013 15

Note 1 - Summary of Significa19

Note 1 - Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Balance at December 31, 2015 (Amounts in thousands) Level I Level II Level III Total Certificates of deposit 122 - - 122 Total assets 122 - - 122 Warrant liabilities - - 509 509 Derivative Liability - - 2,348 2,348 Total liabilities - - 2,857 2,857 Balance at December 31, 2016 (Amounts in thousands) Level I Level II Level III Total Certificates of deposit 106 - - 106 Total assets 106 - - 106 Warrant liabilities - - 5,307 5,307 Derivative Liability 8,122 8,122 Total liabilities - - 13,429 13,429
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Level III Level III Warrant Derivative (Dollars in thousands) Liabilities (Dollars in thousands) Liabilities Balance as of December 31, 2014 $ 40,585 Balance as of December 31, 2014 $ - Issuance (exercise) of warrants, net 2,712 Issuance (exercise) of derivatives, net 1,019 Change in fair value (11,665 ) Change in fair value 2,761 Exchange of warrants (31,123 ) Debt Modification (1,432 ) Balance as of December 31, 2015 $ 509 Balance as of December 31, 2015 $ 2,348 Issuance (exercise) of warrants, net 4,821 Issuance (exercise) of derivatives, net - Change in fair value (2,093 ) Change in fair value 5,774 Warrant Exchanged 2,070 Debt Modification - Balance as of December 31, 2016 $ 5,307 Balance as of December 31, 2016 $ 8,122
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	December 31, 2016 December 31, 2015 Expected volatility 104.31% 133.19% Risk-free interest rate 1.20% - 1.93% 0.65 - 1.76% Weighted average expected lives in years 2.25 - 4.99 0.99 - 4.29 Expected dividend 0% 0% December 31, 2016 December 31, 2015 Expected volatility 104.31 % 133.19 % Risk-free interest rate 0.44 % 0.23 % Weighted average expected lives in years 0.05 1.05 Expected dividend 0 % 0 %

Note 2 - Accounts Receivable (T

Note 2 - Accounts Receivable (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	December 31, (in thousands) 2016 2015 Healthcare fees $ 1,050 $ 587 Other 2 3 Total receivables $ 1,052 $ 590 Less allowance for doubtful accounts - - Total receivables, net $ 1,052 $ 590

Note 3 - Property and Equipme21

Note 3 - Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Property, Plant and Equipment [Table Text Block]	(in thousands) 2016 2015 Furniture and equipment $ 1,712 $ 1,585 Leasehold improvements 318 318 Total property and equipment 2,030 1,903 Less accumulated depreciation and amortization (1,620 ) (1,491 ) Total property and equipment, net $ 410 $ 412

Note 4 - Capital Lease Obliga22

Note 4 - Capital Lease Obligations (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block]	(in thousands) Amount Year ending December 31, 2017 $ 46 2018 34 2019 2 Total minimum lease payments 82 Less amounts representing interest (11 ) Capital lease obligations, net of interest 71 Less current maturities of capital lease obligations (40 ) Long-term capital lease obligations $ 31

Note 5 - Income Taxes (Tables)

Note 5 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	2016 2015 (in thousands) Federal, state and foreign net operating losses $ 78,466 $ 78,474 Stock based compensation 7,429 7,879 Accrued liabilities 664 585 Other temporary differences 4,894 3,045 Valuation allowance (91,453 ) (89,983 ) $ - $ -
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	2016 2015 Federal statutory rate -34.0 % -34.0 % State taxes, net of federal benefit 26.2 % 16.8 % Non-deductible goodwill 0.0 % 0.0 % ISO / ESPP 0.2 % 2.1 % Other -0.5 % -27.0 % Change in valuation allowance 8.0 % 42.1 % Tax provision -0.1 % 0.0 %

Note 7 - Share-based Compensa24

Note 7 - Share-based Compensation (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	Options Outstanding Options Exercisable Range of Exercise Prices Shares Weighted Average Remaining Life (yrs) Weighted Average Price Shares Weighted Average Price $0.00 to $20.00 1,455,000 7.07 $ 5.48 1,293,000 $ 5.89 $20.01 to $1,000.00 9,000 2.03 158.98 9,000 158.98 1,464,000 7.04 $ 6.46 1,302,000 $ 6.99
Schedule of Other Share-based Compensation, Activity [Table Text Block]	December 31, 2016 Description Shares Weighted Average Exercise Price Warrants issued in connection with equity offering - $ - Warrants issued in connection with debt agreement 6,156,102 0.85 Warrants issued for services - - 6,156,102 $ 0.85 December 31, 2015 Description Shares Weighted Average Exercise Price Warrants issued in connection with equity offering - $ - Warrants issued in connection with debt agreement 1,465,311 0.30 Warrants issued for services 341,251 2.16 1,806,562 $ 0.65
Employees and Directors [Member]
Notes Tables
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Weighted Avg. Shares Exercise Price Balance, December 31, 2014 378,000 $ 19.59 2015 Granted 1,300,000 2.20 Cancelled/Expired (207,000 ) 3.29 Balance, December 31, 2015 1,471,000 $ 6.51 2016 Granted - - Cancelled/Expired (7,000 ) 11.31 Balance, December 31, 2016 1,464,000 $ 6.49

Note 8 - Commitments and Cont25

Note 8 - Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	(In thousands) Year Amount 2017 $ 376 2018 $ 387 2019 $ 99

Note 1 - Summary of Significa26

Note 1 - Summary of Significant Accounting Policies (Details Textual)	1 Months Ended												12 Months Ended
	Dec. 31, 2016USD ($)$ / sharesshares	Aug. 31, 2016USD ($)$ / sharesshares	Jul. 31, 2016USD ($)$ / sharesshares	Jun. 30, 2016USD ($)$ / sharesshares	May 31, 2016USD ($)$ / sharesshares	Apr. 30, 2016USD ($)$ / sharesshares	Mar. 31, 2016USD ($)$ / sharesshares	Oct. 31, 2015$ / sharesshares	Sep. 30, 2015USD ($)$ / sharesshares	Jul. 31, 2015USD ($)$ / sharesshares	May 31, 2015$ / sharesshares	Apr. 30, 2015$ / sharesshares	Dec. 31, 2016USD ($)$ / sharesshares	Dec. 31, 2015USD ($)$ / sharesshares	Dec. 31, 2014USD ($)
Cash and Cash Equivalents, at Carrying Value	$ 851,000												$ 851,000	$ 916,000	$ 708,000
Working Capital Deficit	$ 20,700,000												20,700,000
Net Cash Provided by (Used in) Operating Activities, Continuing Operations													$ (5,726,000)	(5,168,000)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares	1,464,089												1,464,089
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares	303,674												303,674
Share-based Compensation													$ 697,000	$ 1,397,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares													0	1,300,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares													9,344,214	3,277,744
Cash and Cash Equivalents Uninsured Amount	$ 676,000												$ 676,000
Stock Issued During Period, Shares, Warrants Exchanged | shares											21,277,220
Class of Warrant or Right, Exchanged During Period, Exercise Price | $ / shares											$ 0.58
Gain (Loss) on Exchange of Warrants													0	$ (4,410,000)
Stock Issued During Period, Shares, New Issues | shares								200,000
Proceeds from Issuance or Sale of Equity														2,463,000
Proceeds from Related Party Debt													5,505,000
Derivative, Gain (Loss) on Derivative, Net													2,100,000	11,700,000
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings													$ 5,800,000	$ 2,800,000
Customer Concentration Risk [Member] | Sales Revenue, Net [Member]
Concentration Risk, Number of Customers													2	3
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Two Customers [Member]
Concentration Risk, Percentage													78.00%
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Three Customers [Member]
Concentration Risk, Percentage														82.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member]
Concentration Risk, Number of Customers													2	3
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Two Customers [Member]
Concentration Risk, Percentage													81.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Three Customers [Member]
Concentration Risk, Percentage														90.00%
Acuitas [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares		2,028,029	431,818	363,636	306,818	200,000	450,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 0.33	$ 0.33	$ 0.33	$ 0.33	$ 0.47	$ 0.47
Class of Warrant or Right, Outstanding | shares						284,848	640,909
Proceeds from Issuance of Debt		$ 225,000
Warrant Term			5 years	5 years	5 years	5 years	5 years
Acuitas [Member] | Exchange of Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares		2,993,561
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 1.10
Senior Promissory Note [Member] | Acuitas [Member] | Exchanged Senior Demand Notes [Member]
Debt Instrument, Face Amount	$ 2,800,000	$ 2,800,000											$ 2,800,000
Acuitas [Member] | March 2016 Promissory Note [Member]
Debt Instrument, Face Amount							$ 900,000
Debt Instrument, Interest Rate, Stated Percentage							8.00%
Proceeds from Issuance of Debt							$ 900,000
Debt Instrument, Term							30 days
Debt Instrument, Interest Rate, Stated Percentage After Maturity Date							12.00%
Acuitas [Member] | April 2016 Promissory Note [Member]
Debt Instrument, Face Amount						$ 1,300,000
Proceeds from Issuance of Debt						$ 400,000
Acuitas [Member] | May 2016 Promissory Note [Member]
Debt Instrument, Face Amount					$ 1,700,000
Proceeds from Issuance of Debt					$ 405,000
Acuitas [Member] | June 2016 Promissory Notes [Member]
Debt Instrument, Face Amount				$ 2,200,000
Proceeds from Issuance of Debt				480,000
Short-term Debt				$ 2,200,000
Acuitas [Member] | July 2016 Promissory Note [Member]
Debt Instrument, Face Amount			$ 2,800,000
Proceeds from Issuance of Debt			570,000
Short-term Debt			$ 2,800,000
Acuitas [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares		2,028,029												935,008
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 0.33												$ 0.30
Stock Issued During Period, Shares, New Issues | shares														6,953,334
Proceeds from Issuance or Sale of Equity									$ 463,000					$ 2,100,000
Acuitas [Member] | Exchange of Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares		2,993,561
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 1.10
Acuitas [Member] | July 2015 Convertible Debenture [Member]
Debt Instrument, Face Amount										$ 3,550,000
Debt Instrument, Interest Rate, Stated Percentage										12.00%
Debt Instrument, Convertible, Conversion Price | $ / shares								$ 0.30		$ 1.90
Acuitas [Member] | Senior Promissory Note [Member] | Exchanged Senior Demand Notes [Member]
Debt Instrument, Face Amount		$ 2,800,000
Director [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares		875,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 1.10
Warrant Term		5 years
Proceeds from Related Party Debt		$ 2,800,000
Investors [Member] | December 2016 Warrants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 1.10												$ 1.10
Warrant Term	5 years
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion	40.00%												40.00%
Class of Warrant or Right, Issued During Period | shares	2,022,835
Investors [Member] | Debentures [Member]
Debt Instrument, Face Amount	$ 5,600,000												$ 5,600,000
Debt Instrument, Interest Rate, Stated Percentage	8.00%												8.00%
Investors [Member] | December 2016 Convertible Debenture [Member]
Debt Instrument, Face Amount	$ 2,800,000												$ 2,800,000
Debt Instrument, Interest Rate, Stated Percentage	8.00%												8.00%
Shamus [Member]
Stock Issued During Period, Shares, New Issues | shares														956,667
Proceeds from Issuance or Sale of Equity														$ 287,000
Shamus [Member] | Shamus Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares		318,182
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 0.85	$ 1.10											$ 0.85
Warrant Term	5 years	5 years
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion	75.00%												75.00%
Class of Warrant or Right, Issued During Period | shares	264,706
Shamus [Member] | Senior Promissory Note [Member]
Debt Instrument, Face Amount		$ 1,000,000
Shamus [Member] | Debentures [Member]
Warrant Term													5 years
Shamus [Member] | December 2016 Convertible Debenture [Member]
Debt Instrument, Interest Rate, Stated Percentage	8.00%												8.00%
Proceeds from Issuance of Debt	$ 300,000												$ 300,000
Minimum [Member] | Furniture and Equipment [Member]
Property, Plant and Equipment, Useful Life													2 years
Minimum [Member] | Leasehold Improvements [Member]
Property, Plant and Equipment, Useful Life													5 years
Maximum [Member] | Furniture and Equipment [Member]
Property, Plant and Equipment, Useful Life													7 years
Maximum [Member] | Leasehold Improvements [Member]
Property, Plant and Equipment, Useful Life													7 years
Twenty Ten Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares	1,825,000												1,825,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period													10 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares	1,464,089												1,464,089
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares	303,674												303,674
Share-based Compensation													$ 697,000	$ 1,400,000
Twenty Ten Stock Incentive Plan [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period													3 years
Twenty Ten Stock Incentive Plan [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period													5 years
April 2015 Warrants [Member]
Warrants and Rights Outstanding Duration												5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares												530,303
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares									$ 0.30			$ 2
Class or Warrant or Right, Exercised During the Period | shares			66,288
Class of Warrant or Right, Outstanding | shares	464,015												464,015
July 2015 Convertible Debenture [Member]
Debt Instrument, Convertible, Conversion Price | $ / shares										$ 1.90
July 2015 Convertible Debenture [Member] | Acuitas [Member]
Warrants and Rights Outstanding Duration										5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares										935,008
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares										$ 1.90
Debt Instrument, Face Amount										$ 3,550,000
Debt Instrument, Interest Rate, Stated Percentage										12.00%
Debt Instrument, Convertible, Conversion Price | $ / shares										$ 1.90
September Offering [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares										$ 0.30
September Offering [Member] | Acuitas [Member]
Debt Instrument, Convertible, Conversion Price | $ / shares									$ 0.30
Stock Issued During Period, Shares, New Issues | shares									1,500,000

Note 1 - Summary of Significa27

Note 1 - Summary of Significant Accounting Policies - Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Certificates of deposit	$ 106	$ 122
Total assets	106	122
Warrant liabilities	5,307	509
Long term derivative liability		2,348
Total liabilities	13,429	2,857
Short term derivative liability	8,122
Fair Value, Inputs, Level 1 [Member]
Certificates of deposit	106	122
Total assets	106	122
Warrant liabilities
Long term derivative liability
Total liabilities
Short term derivative liability
Fair Value, Inputs, Level 2 [Member]
Certificates of deposit
Total assets
Warrant liabilities
Long term derivative liability
Total liabilities
Short term derivative liability
Fair Value, Inputs, Level 3 [Member]
Certificates of deposit
Total assets
Warrant liabilities	5,307	509
Long term derivative liability		2,348
Total liabilities	13,429	$ 2,857
Short term derivative liability	$ 8,122

Note 1 - Summary of Significa28

Note 1 - Summary of Significant Accounting Policies - Fair Value Measurements Using Significant Level III Inputs (Details) - Fair Value, Inputs, Level 3 [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Warrants [Member]
Balance	$ 509	$ 40,585
Issuance (exercise) of warrants, net	4,821	2,712
Change in fair value	(2,093)	(11,665)
Exchanges		(31,123)
Balance	5,307	509
Warrant Exchanged	2,070
Derivative Financial Instruments, Liabilities [Member]
Balance	2,348
Issuance (exercise) of warrants, net		1,019
Change in fair value	5,774	2,761
Exchanges		(1,432)
Balance	8,122	$ 2,348
Warrant Exchanged

Note 1 - Summary of Significa29

Note 1 - Summary of Significant Accounting Policies - Fair Value Assumptions (Details)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Warrant Liability [Member]
Expected volatility	104.31%	133.19%
Risk-free interest rate
Weighted average expected lives in years (Year)
Expected dividend	0.00%	0.00%
Warrant Liability [Member] | Minimum [Member]
Expected volatility
Risk-free interest rate	1.20%	0.65%
Weighted average expected lives in years (Year)	2 years 91 days	361 days
Expected dividend
Warrant Liability [Member] | Maximum [Member]
Expected volatility
Risk-free interest rate	1.93%	1.76%
Weighted average expected lives in years (Year)	4 years 361 days	4 years 105 days
Expected dividend
Derivative Liability [Member]
Expected volatility	104.31%	133.19%
Risk-free interest rate	0.44%	0.23%
Weighted average expected lives in years (Year)	18 days	1 year 18 days
Expected dividend	0.00%	0.00%

Note 2 - Accounts Receivable (D

Note 2 - Accounts Receivable (Details Textual) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Allowance for Doubtful Accounts Receivable	$ 0	$ 0

Note 2 - Accounts Receivable -

Note 2 - Accounts Receivable - Summary of Accounts Receivables (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Receivables gross	$ 1,052,000	$ 590,000
Less allowance for doubtful accounts	0	0
Total receivables, net	1,052,000	590,000
Healthcare Fees [Member]
Receivables gross	1,050,000	587,000
Other Receivable [Member]
Receivables gross	$ 2,000	$ 3,000

Note 3 - Property and Equipme32

Note 3 - Property and Equipment (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Depreciation	$ 141,000	$ 110,000

Note 3 - Property and Equipme33

Note 3 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Furniture and equipment	$ 1,712	$ 1,585
Leasehold improvements	318	318
Total property and equipment	2,030	1,903
Less accumulated depreciation and amortization	(1,620)	(1,491)
Total property and equipment, net	$ 410	$ 412

Note 4 - Capital Lease Obliga34

Note 4 - Capital Lease Obligations (Details Textual) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Property, Plant, and Equipment Other, Accumulated Depreciation	$ 47,000	$ 43,000
Furniture and Equipment [Member]
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Other Property, Plant, and Equipment, Gross	$ 103,000	$ 110,000

Note 4 - Capital Lease Obliga35

Note 4 - Capital Lease Obligations - Future Minimum Lease Payments Required Under the Capital Leases (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
2,017	$ 46
2,018	34
2,019	2
Total minimum lease payments	82
Less amounts representing interest	(11)
Capital lease obligations, net of interest	71
Less current maturities of capital lease obligations	(40)
Long-term capital lease obligations	$ 31	$ 66

Note 5 - Income Taxes (Details

Note 5 - Income Taxes (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	$ 0	$ 0
Earliest Tax Year [Member]
Open Tax Year	2,011
Latest Tax Year [Member]
Open Tax Year	2,015
Domestic Tax Authority [Member]
Operating Loss Carryforwards	$ 222,000
State and Local Jurisdiction [Member]
Operating Loss Carryforwards		$ 170,000

Note 5 - Income Taxes - Primary

Note 5 - Income Taxes - Primary Components of Net Deferred Tax Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Federal, state and foreign net operating losses	$ 78,466	$ 78,474
Stock based compensation	7,429	7,879
Accrued liabilities	664	585
Other temporary differences	4,894	3,045
Valuation allowance	$ (91,453)	$ (89,983)

Note 5 - Income Taxes - Reconci

Note 5 - Income Taxes - Reconciliation Between the Statutory Federal Income Tax Rate and the Effective Income Tax Rate (Details)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Federal statutory rate	(34.00%)	(34.00%)
State taxes, net of federal benefit	26.20%	16.80%
Non-deductible goodwill	0.00%	0.00%
ISO / ESPP	0.20%	2.10%
Other	0.50%	27.00%
Change in valuation allowance	8.00%	42.10%
Tax provision	0.10%	0.00%

Note 6 - Equity Financings (Det

Note 6 - Equity Financings (Details Textual) - USD ($)	1 Months Ended			12 Months Ended
	Oct. 31, 2015	Sep. 30, 2015	May 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Proceeds from Issuance or Sale of Equity					$ 2,463,000
Stock Issued During Period, Shares, New Issues	200,000
Stock Issued During Period, Shares, Warrants Exchanged			21,277,220
Class of Warrant or Right, Exchanged During Period, Exercise Price			$ 0.58
Acuitas, Shamus, and Steve Gorlin [Member]
Proceeds from Issuance or Sale of Equity	$ 2,000,000
Stock Issued During Period, Shares, New Issues	6,700,000
Shares Issued, Price Per Share	$ 0.30
Acuitas [Member]
Proceeds from Issuance or Sale of Equity		$ 463,000			$ 2,100,000
Stock Issued During Period, Shares, New Issues					6,953,334
Acuitas [Member] | September Offering [Member]
Proceeds from Issuance or Sale of Equity		$ 463,000
Stock Issued During Period, Shares, New Issues		1,500,000

Note 7 - Share-based Compensa40

Note 7 - Share-based Compensation (Details Textual) - USD ($)	1 Months Ended		12 Months Ended
	Oct. 31, 2015	May 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number			1,464,089
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant			303,674
Share-based Compensation			$ 697,000	$ 1,397,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			0	1,300,000
Stock Issued During Period, Shares, New Issues	200,000
Stock Issued During Period, Shares, Warrants Exchanged		21,277,220
Class of Warrant or Right, Exchanged During Period, Exercise Price		$ 0.58
Stock Issued During Period, Value, Issued for Services			$ 235,000	$ 172,000
Common Stock [Member]
Stock Issued During Period, Shares, New Issues				8,410,001
Stock Issued During Period, Shares, Issued for Services			235,000	76,055
Stock Issued During Period, Value, Issued for Services			$ 235,000	$ 172,000
Stock Options Employees and Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			0
Allocated Share-based Compensation Expense			$ 697,000	$ 1,400,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized			$ 318,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			1 year 109 days
Warrants Nonemployees [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			0	300,000
Stock Options and Warrants Nonemployees [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			0	0
Allocated Share-based Compensation Expense			$ 0	$ 3,000
Twenty Ten Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			1,825,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period			10 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number			1,464,089
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant			303,674
Share-based Compensation			$ 697,000	$ 1,400,000
Twenty Ten Stock Incentive Plan [Member] | Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross				250,000
Twenty Ten Stock Incentive Plan [Member] | Non-employee Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross				1,050,000
Twenty Ten Stock Incentive Plan [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			3 years
Twenty Ten Stock Incentive Plan [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			5 years
Employee Stock Purchase Plan [Member]
Allocated Share-based Compensation Expense			$ 0	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent			85.00%
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate			10.00%
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period				0

Note 7 - Share-based Compensa41

Note 7 - Share-based Compensation - Employee and Director Stock Option Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Granted (in shares)	0	1,300,000
Balance (in shares)	1,464,000
Balance (in dollars per share)	$ 6.46
Employees and Directors [Member]
Balance (in shares)	1,471,000	378,000
Balance (in dollars per share)	$ 6.51	$ 19.59
Granted (in shares)		1,300,000
Granted (in dollars per share)		$ 2.20
Cancelled/Expired (in shares)	(7,000)	(207,000)
Cancelled/Expired (in dollars per share)	$ 11.31	$ 3.29
Balance (in shares)	1,464,000	1,471,000
Balance (in dollars per share)	$ 6.49	$ 6.51

Note 7 - Share-based Compensa42

Note 7 - Share-based Compensation - Options by Exercise Price Range (Details)	12 Months Ended
	Dec. 31, 2016$ / sharesshares
Options Outstanding Shares (in shares) | shares	1,464,000
Options Outstanding Weighted Average Remaining Life (Year)	7 years 14 days
Options Outstanding Weighted Average Price (in dollars per share)	$ 6.46
Options Exercisable Shares (in shares) | shares	1,302,000
Options Exercisable Weighted Average Price (in dollars per share)	$ 6.99
Range One [Member]
Lower Exercise Price Limit (in dollars per share)	0
Upper Exercise Price Limit (in dollars per share)	$ 20
Options Outstanding Shares (in shares) | shares	1,455,000
Options Outstanding Weighted Average Remaining Life (Year)	7 years 25 days
Options Outstanding Weighted Average Price (in dollars per share)	$ 5.48
Options Exercisable Shares (in shares) | shares	1,293,000
Options Exercisable Weighted Average Price (in dollars per share)	$ 5.89
Range Two [Member]
Lower Exercise Price Limit (in dollars per share)	20.01
Upper Exercise Price Limit (in dollars per share)	$ 1,000
Options Outstanding Shares (in shares) | shares	9,000
Options Outstanding Weighted Average Remaining Life (Year)	2 years 10 days
Options Outstanding Weighted Average Price (in dollars per share)	$ 158.98
Options Exercisable Shares (in shares) | shares	9,000
Options Exercisable Weighted Average Price (in dollars per share)	$ 158.98

Note 7 - Share-based Compensa43

Note 7 - Share-based Compensation - Stock Options and Warrants Granted to Non-employees for Services Outstanding (Details) - Stock Options and Warrants Nonemployees [Member] - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Warrants Issued (in shares)	6,156,102	1,806,562
Warrants Issued Weighted Average Exercise Price (in dollars per share)	$ 0.85	$ 0.65
Issued in Connection With Equity Offering [Member]
Warrants Issued (in shares)
Warrants Issued Weighted Average Exercise Price (in dollars per share)
Issued in Connection With Debt Agreement [Member]
Warrants Issued (in shares)	6,156,102	1,465,311
Warrants Issued Weighted Average Exercise Price (in dollars per share)	$ 0.85	$ 0.30
Warrants Issued for Services [Member]
Warrants Issued (in shares)		341,251
Warrants Issued Weighted Average Exercise Price (in dollars per share)		$ 2.16

Note 8 - Commitments and Cont44

Note 8 - Commitments and Contingencies (Details Textual)	12 Months Ended
	Dec. 31, 2016USD ($)a	Dec. 31, 2015USD ($)
Operating Leases, Rent Expense, Net	$ 296,000	$ 294,000
Principal Executive and Administrative Offices [Member]
Area of Real Estate Property | a	9,120
Operating Lease Monthly Rent	$ 31,000

Note 8 - Commitments and Cont45

Note 8 - Commitments and Contingencies - Future Minimum Payments, Under Non-cancelable Operating Leases (Details) $ in Thousands	Dec. 31, 2016USD ($)
2,017	$ 376
2,018	387
2,019	$ 99

Note 9 - Related Party Disclo46

Note 9 - Related Party Disclosure (Details Textual) - USD ($)	1 Months Ended				12 Months Ended
	Dec. 31, 2016	Aug. 31, 2016	Oct. 31, 2015	Sep. 30, 2015	Dec. 31, 2016	Dec. 31, 2015
Stock Issued During Period, Shares, New Issues			200,000
Proceeds from Related Party Debt					$ 5,505,000
Proceeds from Issuance or Sale of Equity						2,463,000
Due to Related Parties, Current	$ 9,796,000				9,796,000
Investor [Member]
Stock Issued During Period, Shares, New Issues						300,000
Proceeds from Issuance of Common Stock						$ 90,000
Chairman and Chief Executive Officer [Member]
Proceeds from Related Party Debt		$ 225,000
Repayments of Related Party Debt		$ 225,000
Due to Related Parties, Current	194,000				194,000	$ 130,000
Chairman and Chief Executive Officer [Member] | Acuitas [Member]
Ownership Percentage by Related Party						100.00%
Acuitas [Member]
Stock Issued During Period, Shares, New Issues						6,953,334
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		2,028,029				935,008
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.33				$ 0.30
Proceeds from Issuance or Sale of Equity				$ 463,000		$ 2,100,000
Convertible Debt	3,700,000				3,700,000
Interest on Convertible Debt, Related Party, Net of Tax	$ 577,000				$ 577,000
Acuitas [Member] | Exchange of Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		2,993,561
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 1.10
Acuitas [Member] | Senior Promissory Note [Member] | Exchanged Senior Demand Notes [Member]
Debt Instrument, Face Amount		$ 2,800,000
Investors [Member] | December 2016 Warrants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.10				$ 1.10
Warrant Term	5 years
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion	40.00%				40.00%
Class of Warrant or Right, Issued During Period	2,022,835
Investors [Member] | December 2016 Convertible Debenture [Member]
Debt Instrument, Face Amount	$ 2,800,000				$ 2,800,000
Debt Instrument, Interest Rate, Stated Percentage	8.00%				8.00%
Investors [Member] | Debentures [Member]
Debt Instrument, Face Amount	$ 5,600,000				$ 5,600,000
Debt Instrument, Interest Rate, Stated Percentage	8.00%				8.00%
Shamus [Member]
Stock Issued During Period, Shares, New Issues						956,667
Proceeds from Issuance or Sale of Equity						$ 287,000
Shamus [Member] | Shamus Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		318,182
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.85	$ 1.10			$ 0.85
Warrant Term	5 years	5 years
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion	75.00%				75.00%
Class of Warrant or Right, Issued During Period	264,706
Shamus [Member] | Shamus Warrants [Member] | Subscription Agreement Exchange [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.10				$ 1.10
Warrant Term	5 years
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion	40.00%				40.00%
Class of Warrant or Right, Issued During Period	363,636
Shamus [Member] | Senior Promissory Note [Member]
Debt Instrument, Face Amount		$ 1,000,000
Shamus [Member] | Senior Promissory Note [Member] | Subscription Agreement Exchange [Member]
Extinguishment of Debt, Amount	$ 1,000,000
Shamus [Member] | December 2016 Convertible Debenture [Member]
Debt Instrument, Interest Rate, Stated Percentage	8.00%				8.00%
Proceeds from Issuance of Debt	$ 300,000				$ 300,000
Shamus [Member] | Debentures [Member]
Warrant Term					5 years
Shamus [Member] | Debentures [Member] | Subscription Agreement Exchange [Member]
Debt Instrument, Face Amount	$ 1,000,000				$ 1,000,000
Debt Instrument, Interest Rate, Stated Percentage	8.00%				8.00%
Shamus [Member] | Shamus Warrants [Member]
Warrant Term	5 years

Note 10 - Short-term Debt (Deta

Note 10 - Short-term Debt (Details Textual) - USD ($)	1 Months Ended										6 Months Ended	12 Months Ended
	Dec. 31, 2016	Aug. 31, 2016	Jul. 31, 2016	Jun. 30, 2016	May 31, 2016	Apr. 30, 2016	Mar. 31, 2016	Oct. 31, 2015	Jul. 31, 2015	Apr. 30, 2015	Jun. 30, 2015	Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2015
Proceeds from Convertible Debt												$ 300,000	$ 5,910,000
Repayments of Convertible Debt													2,681,000
Gain (Loss) on Extinguishment of Debt								$ (195,000)				(2,424,000)	(195,000)
Proceeds from Related Party Debt												$ 5,505,000
Acuitas [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.33	$ 0.33	$ 0.33	$ 0.33	$ 0.47	$ 0.47
Repayments of Convertible Debt		$ 225,000
Proceeds from Issuance of Debt		$ 225,000
Warrant Term			5 years	5 years	5 years	5 years	5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		2,028,029	431,818	363,636	306,818	200,000	450,000
Class of Warrant or Right, Outstanding						284,848	640,909
Acuitas [Member] | Exchange of Warrants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 1.10
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		2,993,561
July 2015 Convertible Debenture [Member]
Fair Value Inputs, Discount Rate									12.00%
Debt Instrument, Convertible, Conversion Price									$ 1.90
September Offering [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights									$ 0.30
Acuitas [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.33											$ 0.30
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		2,028,029											935,008
Acuitas [Member] | Exchange of Warrants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 1.10
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		2,993,561
Acuitas [Member] | July 2015 Convertible Debenture [Member]
Debt Instrument, Face Amount									$ 3,550,000
Debt Instrument, Interest Rate, Stated Percentage									12.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights									$ 1.90
Debt Instrument, Convertible, Conversion Price									$ 1.90
Class of Warrant or Right, Number of Securities Called by Warrants or Rights									935,008
Acuitas [Member] | September Offering [Member]
Debt Instrument, Convertible, Conversion Price														$ 0.30
Director [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 1.10
Warrant Term		5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		875,000
Proceeds from Related Party Debt		$ 2,800,000
Investors [Member] | December 2016 Warrants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.10											$ 1.10
Warrant Term	5 years
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion	40.00%											40.00%
Class of Warrant or Right, Issued During Period	2,022,835
Shamus [Member] | Shamus Warrants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.85	$ 1.10										$ 0.85
Warrant Term	5 years	5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		318,182
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion	75.00%											75.00%
Class of Warrant or Right, Issued During Period	264,706
April 2015 Bridge Notes [Member]
Proceeds from Convertible Debt										$ 2,000,000
Debt Instrument, Face Amount										$ 2,120,000
Debt Instrument, Interest Rate, Stated Percentage										12.00%
Net Proceeds of Convertible Debt										$ 1,815,000
Class of Warrant or Right, Exercise Price of Warrants or Rights										$ 2				$ 0.30
Fair Value Inputs, Discount Rate										12.00%
April 2015 Bridge Notes [Member] | Crede [Member]
Repayments of Related Party Debt											$ 560,000
Promissory Note [Member] | Acuitas [Member]
Debt Instrument, Face Amount									$ 3,350,000
Debt Instrument, Interest Rate, Stated Percentage									8.00%
Proceeds from Short-term Debt, Maturing in Three Months or Less									$ 3,350,000
Repayments of Convertible Debt									$ 2,200,000
Promissory Note [Member] | Acuitas [Member] | Interest Rate Increase After Maturity [Member]
Debt Instrument, Interest Rate, Stated Percentage									12.00%
March 2016 Promissory Note [Member] | Acuitas [Member]
Debt Instrument, Face Amount							$ 900,000
Debt Instrument, Interest Rate, Stated Percentage							8.00%
Proceeds from Issuance of Debt							$ 900,000
Debt Instrument, Term							30 days
Debt Instrument, Interest Rate, Stated Percentage After Maturity Date							12.00%
April 2016 Promissory Note [Member] | Acuitas [Member]
Debt Instrument, Face Amount						$ 1,300,000
Proceeds from Issuance of Debt						$ 400,000
May 2016 Promissory Note [Member] | Acuitas [Member]
Debt Instrument, Face Amount					$ 1,700,000
Proceeds from Issuance of Debt					$ 405,000
June 2016 Promissory Notes [Member] | Acuitas [Member]
Debt Instrument, Face Amount				$ 2,200,000
Proceeds from Issuance of Debt				$ 480,000
July 2016 Promissory Note [Member] | Acuitas [Member]
Debt Instrument, Face Amount			$ 2,800,000
Proceeds from Issuance of Debt			$ 570,000
Senior Promissory Note [Member] | Acuitas [Member] | Exchanged Senior Demand Notes [Member]
Debt Instrument, Face Amount	$ 2,800,000	$ 2,800,000										$ 2,800,000
Senior Promissory Note [Member] | Acuitas [Member] | Exchanged Senior Demand Notes [Member]
Debt Instrument, Face Amount		2,800,000
Senior Promissory Note [Member] | Shamus [Member]
Debt Instrument, Face Amount		$ 1,000,000
Debentures [Member] | Investors [Member]
Debt Instrument, Face Amount	$ 5,600,000											$ 5,600,000
Debt Instrument, Interest Rate, Stated Percentage	8.00%											8.00%
Debentures [Member] | Shamus [Member]
Warrant Term												5 years
December 2016 Convertible Debenture [Member] | Investors [Member]
Debt Instrument, Face Amount	$ 2,800,000											$ 2,800,000
Debt Instrument, Interest Rate, Stated Percentage	8.00%											8.00%
December 2016 Convertible Debenture [Member] | Shamus [Member]
Debt Instrument, Interest Rate, Stated Percentage	8.00%											8.00%
Proceeds from Issuance of Debt	$ 300,000											$ 300,000

Note 11 - Subsequent Events (De

Note 11 - Subsequent Events (Details Textual) - USD ($)	Feb. 27, 2017	Jan. 31, 2017	Dec. 31, 2016	Aug. 31, 2016	Dec. 31, 2015
Acuitas [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 0.33	$ 0.30
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				2,028,029	935,008
Shamus [Member] | Shamus Warrants [Member]
Warrant Term			5 years	5 years
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion			75.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 0.85	$ 1.10
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				318,182
Subsequent Event [Member] | Twenty Seventeen Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized	14,000,000
Subsequent Event [Member] | Twenty Ten Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized	1,500,000
Subsequent Event [Member] | Acuitas [Member] | January 2017 Warrants [Member]
Warrant Term		5 years
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion		100.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.85
Subsequent Event [Member] | Acuitas [Member] | December 2016 Warrants [Member]
Class of Warrant or Right, Additional Percent of Securities Called by Warrants or Rights Upon Conversion		25.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		827,293
Subsequent Event [Member] | Acuitas [Member] | January 2017 Convertible Debenture [Member]
Proceeds from Issuance of Debt		$ 1,300,000
Debt Instrument, Interest Rate, Stated Percentage		8.00%
Subsequent Event [Member] | Shamus [Member] | Shamus Warrants [Member]
Class of Warrant or Right, Percent of Securities Called by Warrants or Rights Upon Conversion		100.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		352,941